agilon health, inc. vs. Cryo-Cell International Inc.
Cryo-Cell International Inc. (CCEL) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| AGL | CCEL | |
|---|---|---|
| Market Cap | $1.53 billion | $27.09 million |
| Revenue (TTM) | $5.92 billion | — |
| Net Income (TTM) | $-232,217,000 | — |
AGL leads on 1 of 1 size & scale factors.
Valuation
| AGL | CCEL | |
|---|---|---|
| Price / Book | 6.74 | — |
| Price / Sales | 0.26 | — |
AGL and CCEL split the valuation factors evenly.
Profitability
| AGL | CCEL | |
|---|---|---|
| Net Margin | -3.92% | — |
| Return on Equity | -102.06% | — |
AGL and CCEL split the profitability factors evenly.
Dividend
| AGL | CCEL | |
|---|---|---|
| Dividend Yield | 0.47% | 17.86% |
CCEL leads on 1 of 1 dividend factors.
Risk & Sentiment
| AGL | CCEL | |
|---|---|---|
| Short Interest | 10.58% | 0.00% |
CCEL leads on 1 of 1 risk & sentiment factors.
Dig deeper: AGL overview, AGL financials, CCEL overview, CCEL financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.